GEROSYNTH Trademark

Trademark Overview

On Wednesday, April 6, 2022, a trademark application was filed for GEROSYNTH with the United States Patent and Trademark Office. The USPTO has given the GEROSYNTH trademark a serial number of 97349386. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, October 3, 2024. This trademark is owned by Gerosynth Laboratories, Inc.. The GEROSYNTH trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of cancer
gerosynth

General Information

Serial Number97349386
Word MarkGEROSYNTH
Filing DateWednesday, April 6, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, October 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2023

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 11, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGerosynth Laboratories, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLakeville, MN 55044
Party NameGerosynth Laboratories, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLakeville, MN 55044

Trademark Events

Event DateEvent Description
Saturday, April 9, 2022NEW APPLICATION ENTERED
Monday, April 11, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 24, 2023ASSIGNED TO EXAMINER
Tuesday, January 24, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 28, 2023PUBLISHED FOR OPPOSITION
Tuesday, February 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 9, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 9, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 9, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 24, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 24, 2023SOU EXTENSION 1 FILED
Tuesday, October 24, 2023SOU EXTENSION 1 GRANTED
Friday, October 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 24, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, April 24, 2024SOU EXTENSION 2 FILED
Wednesday, April 24, 2024SOU EXTENSION 2 GRANTED
Thursday, April 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 1, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 1, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 3, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 3, 2024SOU EXTENSION 3 FILED
Thursday, October 3, 2024SOU EXTENSION 3 GRANTED

Related Keywords

gerosynth cancer treatment preparations pharmaceutical